|
|
|
Volumn 71, Issue 4, 1997, Pages 1211-1312
|
|
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
ANALYTICAL APPROACH;
ARTICLE;
BREAST TUMOR;
ECONOMICS;
ETHICS;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GENETIC COUNSELING;
GENETIC PRIVACY;
GENETIC SCREENING;
GENETIC SERVICE;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
HEALTH CARE QUALITY;
HUMAN;
INDUSTRY;
INTERVIEW;
LABORATORY;
LEGAL APPROACH;
LEGAL ASPECT;
LEGAL LIABILITY;
PEER REVIEW;
PSYCHOLOGICAL ASPECT;
SOCIAL CONTROL;
STANDARD;
TUMOR SUPPRESSOR GENE;
UNITED STATES;
ANALYTICAL APPROACH;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
ADVISORY COMMITTEES;
BREAST NEOPLASMS;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
GENETIC COUNSELING;
GENETIC PRIVACY;
GENETIC SCREENING;
GENETIC SERVICES;
GOVERNMENT REGULATION;
HUMANS;
INDUSTRY;
INTERVIEWS;
LABORATORIES;
LIABILITY, LEGAL;
PEER REVIEW, HEALTH CARE;
QUALITY ASSURANCE, HEALTH CARE;
SOCIAL CONTROL, FORMAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0342562466
PISSN: 00413992
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
